About Anagin

Our Mission and Goals

We are developing therapies that target mechanisms which result in neuropsychiatric diseases through abnormal  neuroplasticity, inflammation, excitotoxicity and neurodegeneration.

Our vision is to provide disease modifying and curative therapies for patient’s suffering from post-traumatic stress disorder (PTSD), traumatic brain injury, neuropathic pain, depression, Parkinson’s disease and Alzheimer’s disease

Mission and Goals
Play Video

Our Focus

Though we cannot undo the traumatic experience from a patient’s life, Anagin believes we can eliminate the persistence of the feelings it produced. The high prevalence of PTSD and its treatment in veterans and civilian populations is a high priority for the Department of Defense, Veteran’s Affairs and the National Institute of Mental Health.

With our experienced and talented team focused on science, speed, development and use of funds, Anagin intends to expand from its initial focus on PTSD to other breakthrough therapies for traumatic brain injury, neuropathic pain, depression, Parkinson’s disease and Alzheimer’s disease.


Research and Development